Back to all posts

ADHD and Sleep: How Medication Affects Your Sleep + Solutions

Why ADHD and sleep problems go hand in hand — and how stimulants affect sleep architecture. Practical strategies for better sleep while on ADHD medication.

·13 min read·Written by Titrate Editorial Team·Medically reviewed against primary sources by Ohad Fisher
Primary sources referenced: [1], [2], [3], [4]

Get new titration guides by email

Occasional, evidence-based guides on medication tracking and titration — no noise.

No spam, unsubscribe anytime.

title: "ADHD and Sleep: How Medication Affects Your Sleep + Solutions" description: "An evidence-based guide to the ADHD-sleep relationship — how stimulants and non-stimulants affect sleep architecture, why ADHD brains struggle with sleep, and practical strategies for better rest during medication titration." date: 2026-07-31 author: "Titrate Medical Review" tags: ["ADHD", "sleep", "insomnia", "DSPS", "circadian rhythm", "stimulants", "non-stimulants", "melatonin", "sleep hygiene", "titration"] readingTime: "11 min read" wordCount: 2300

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Sleep problems during ADHD medication titration are common, but their causes are varied — and the right solution depends on your specific medication, dose, timing, and individual physiology. Always consult your prescriber before changing your medication dose, timing, or adding any supplement (including melatonin). If you experience chest pain, severe shortness of breath, or thoughts of self-harm, seek emergency medical attention immediately.

Table of Contents

  1. The ADHD-Sleep Connection Is Bidirectional
  2. How Stimulants Affect Sleep Architecture
  3. Non-Stimulant Effects on Sleep
  4. Sleep Hygiene for the ADHD Brain (No 'Just Relax' Advice)
  5. Timing Solutions: Dose, Boosters, and Cutoffs
  6. Melatonin: Timing, Dosing, and What the Research Says
  7. When Sleep Problems Signal the Wrong Dose or Formulation
  8. Tracking Sleep Alongside Medication
  9. Sleep Optimization Checklist
  10. When to Discuss Sleep with Your Prescriber
  11. FAQ
  12. Key Takeaways

The ADHD-Sleep Connection Is Bidirectional

If you have ADHD and struggle with sleep, you are not dealing with two separate problems. You are dealing with a single, intertwined system where each condition makes the other worse.

The relationship between ADHD and sleep is bidirectional: poor sleep worsens ADHD symptoms (executive function, emotional regulation, attention), and ADHD symptoms — both treated and untreated — make it harder to sleep well [1]. This creates a feedback loop that can derail even the most carefully planned medication titration.

Sleep disturbances affect an estimated 50–75% of adults with ADHD, compared to roughly 15–35% of the general adult population [2]. These aren't occasional bad nights — they represent persistent, clinically significant sleep problems that demand targeted intervention.

Delayed Sleep Phase Syndrome (DSPS)

The most common sleep disorder co-occurring with ADHD is Delayed Sleep Phase Syndrome (DSPS), a circadian rhythm disorder where your internal clock runs late. While the general population's melatonin naturally rises in the evening to signal sleep, research shows that melatonin release in people with ADHD is delayed by approximately 1.5 to 3 hours compared to neurotypical individuals [3].

This means your body is literally not receiving the "time to sleep" chemical signal at a socially normal hour. You're not failing to fall asleep — your body hasn't started the process yet. Up to 75% of adults with ADHD show a delayed sleep phase, making this the rule rather than the exception [4].

The practical consequence: when you climb into bed at 11 PM, your brain's melatonin levels may be equivalent to what a non-ADHD brain experiences at 8:30 PM. You're biologically two hours early, and no amount of willpower or "just relax" advice can override that.

Restless Leg Syndrome and Periodic Limb Movements

Restless Leg Syndrome (RLS) is significantly more common in people with ADHD. Studies estimate that up to 44% of children with ADHD and 20–33% of adults with ADHD meet criteria for RLS, compared to approximately 5–10% of the general population [5].

The shared mechanism likely involves dopamine dysregulation and iron metabolism — both systems that are implicated in ADHD and RLS independently [6]. When RLS is present, it compounds sleep-onset difficulty: not only is your circadian rhythm delayed, but lying still triggers uncomfortable sensations that make falling asleep physically unpleasant.

Periodic Limb Movements of Sleep (PLMS) — involuntary leg twitching during sleep — are also elevated in ADHD, correlating with more fragmented sleep and reduced sleep efficiency regardless of medication status [7].

Racing Thoughts at Bedtime

The "racehorse mind" phenomenon — where ADHD thoughts accelerate the moment the head hits the pillow — is not simply anxiety. It reflects a real mismatch between the ADHD brain's arousal regulation and the environmental demands of bedtime.

When external stimulation disappears (no phone, no conversation, no task), the ADHD brain generates its own stimulation through internal thought loops. This is compounded by task-switching difficulty: the same executive dysfunction that makes it hard to stop a task during the day also makes it hard to stop a train of thought at night [8].

Together, these three factors — a delayed circadian clock, physical restlessness, and cognitive hyperarousal — mean that the ADHD brain is fighting a three-front war at bedtime every night.

How Stimulants Affect Sleep Architecture

Stimulant medications (amphetamine-based: Adderall, Vyvanse, Dexedrine; and methylphenidate-based: Ritalin, Concerta, Focalin) work by increasing dopamine and norepinephrine availability. These are the same neurotransmitters that promote wakefulness, attention, and arousal. The sleep effects are therefore pharmacological — not a side effect in the sense of an unwanted accident, but a direct consequence of the drug's mechanism.

REM Suppression

The most consistent sleep-architecture finding with stimulant use is REM sleep suppression. Polysomnographic studies show that therapeutic doses of amphetamine-based stimulants reduce REM sleep from a typical 20–22% of total sleep time down to approximately 15–17% — a 20–30% reduction [9].

This effect persists throughout treatment and does not fully resolve with tolerance. The clinical significance of REM suppression is debated, but REM sleep plays a critical role in emotional memory consolidation, mood regulation, and procedural learning. Chronic REM reduction has been associated with emotional dysregulation and increased anxiety — symptoms that can be mistaken for ADHD itself or for a medication side effect.

Interestingly, some studies of methylphenidate in adults with ADHD have found improved sleep efficiency and shortened sleep onset latency compared to the unmedicated baseline, suggesting that the relationship between stimulants and sleep is more nuanced than a simple "stimulants = bad sleep" equation [10]. For some patients, the reduction in ADHD symptoms during the day leads to less anxiety and rumination at night, partially offsetting the direct pharmacological activation.

Delayed Sleep Onset

The most commonly reported sleep complaint from stimulant users is difficulty falling asleep. This is a direct effect of elevated noradrenergic activity: stimulants increase norepinephrine, which promotes wakefulness and delays the natural nighttime decline in arousal [11].

The magnitude of the delay depends on three factors:

Factor Effect on Sleep Onset
Dose timing A dose taken at 10 AM vs. 8 AM can delay sleep onset by 1–2 hours
Formulation Long-acting formulations (Vyvanse, Concerta) have a 12–14 hour tail that can overlap with bedtime
Individual metabolism CYP2D6 poor metabolizers clear amphetamines more slowly, prolonging the wakefulness signal

The key variable is the interval between the last dose and bedtime. For immediate-release stimulants, a 6-hour gap is the general minimum. For extended-release formulations, 10–12 hours is more realistic. Vyvanse, with its 12–14 hour duration, may require a 6:30–7:30 AM dose to clear adequately by an 11 PM bedtime [12].

Reduced Total Sleep Time

When sleep onset is delayed and wake-up time is fixed by work or school obligations, the result is trivially predictable: reduced total sleep time. Studies consistently find that stimulant-treated individuals get 30–60 minutes less sleep per night than their unmedicated baseline, with the reduction concentrated in the first half of the night [13].

This chronic sleep restriction has downstream effects on daytime functioning that can mimic or amplify ADHD symptoms: impaired attention, reduced working memory, increased irritability, and poorer emotional regulation. The result is a paradox where the medication treats ADHD symptoms during the day, but the sleep disruption it causes recreates those same symptoms through a different mechanism.

Non-Stimulant Effects on Sleep

Non-stimulant medications offer a different sleep profile, which is one reason they are chosen when sleep disruption is a primary concern.

Atomoxetine (Strattera): As a selective norepinephrine reuptake inhibitor, atomoxetine increases noradrenergic tone — but the effect is steady-state rather than the peaks-and-valleys pattern of stimulants. Sleep disruption is less common than with stimulants, though some patients report insomnia, while others paradoxically experience sedation [14]. Evening dosing can turn the sedation into an advantage for sleep onset.

Guanfacine ER (Intuniv) and Clonidine ER (Kapvay): These alpha-2 adrenergic agonists reduce central noradrenergic outflow, which produces a calming effect. Sedation is the most common side effect — occurring in 30–40% of patients — and many prescribers recommend evening dosing specifically to leverage this for sleep [15]. However, guanfacine has been associated with increased awake time after sleep onset and reduced slow-wave sleep in some polysomnographic studies [16].

Viloxazine (Qelbree): The newest non-stimulant option, viloxazine acts on both norepinephrine reuptake and serotonin receptor modulation. Clinical trials report lower rates of insomnia compared to atomoxetine, though the data is still emerging [17].

Medication Sleep Effect Best Use Case
Stimulants (IR) Delays onset, reduces REM, may reduce total sleep Early dosing, strict cutoff for afternoon boosters
Stimulants (XR/Prodrug) Extended wakefulness signal, can overlap with bedtime Morning-only dosing, may need IR booster instead
Atomoxetine Mild activation or sedation depending on individual Evening dosing if sedation, morning if activation
Guanfacine/Clonidine Prominent sedation, improves sleep onset Evening dosing, leverage sedation for sleep
Viloxazine Lower insomnia rates than alternatives When sleep is a priority and stimulants aren't tolerated

Sleep Hygiene for the ADHD Brain (No 'Just Relax' Advice)

Standard sleep hygiene advice — "wind down," "avoid screens," "try to relax" — is often worse than useless for ADHD brains. It assumes a baseline neurological capacity for calm that ADHD brains don't have at bedtime. Here is what actually works.

The Stop Rule

The ADHD brain struggles with task-switching, especially when a task is engaging. The "Stop Rule" is a concrete external constraint: set a recurring alarm labeled "STOP" for 90 minutes before your target bedtime. When the alarm goes off, you stop whatever you're doing — no finishing the level, no "one more email," no "just to the end of this chapter." The rule is the rule.

This is not about willpower. This is about outsourcing the decision to an external signal so your executive function doesn't have to negotiate with itself.

The Transition Buffer

The ADHD brain cannot transition directly from stimulation to sleep. It needs a structured buffer zone. The buffer should be:

The buffer works because it replaces the impossible task of "relaxing" with the concrete task of "doing this specific thing for 30 minutes, then this other specific thing."

The Body Temperature Lever

Core body temperature drop is a physiological trigger for sleep onset. You can accelerate this deliberately:

This is a physiological intervention, not a psychological one, and it works regardless of how "wired" your brain feels.

The Physical Anchor

For racing thoughts, anchor your body rather than your mind. Weighted blankets (12–15% of body weight) provide deep pressure stimulation that increases serotonin and reduces cortisol [19]. If you don't have one, lying on your stomach with a pillow under your hips or using a firm body pillow can produce similar grounding input.

The Worry Dump

Set a timer for 5 minutes before the buffer starts. Write down everything on your mind — tasks, worries, ideas, resentment, things you'll forget by morning. This is not journaling for insight. It's a capture system so your brain can stop holding the list in working memory. Close the notebook or put the phone in the other room after the timer goes off.

Timing Solutions: Dose, Boosters, and Cutoffs

Medication timing is the single most impactful variable you can adjust for sleep. Here are the concrete rules.

Early Morning Dosing

Take your stimulant dose within 30 minutes of waking. For extended-release formulations, this means 6:30–8:00 AM for a typical 11 PM bedtime. Every hour you delay the morning dose pushes the medication tail deeper into the evening.

For Vyvanse specifically, the 12–14 hour duration means a 7 AM dose clears around 7–9 PM — compatible with an 11 PM bedtime. A 10 AM dose clears at 10 PM–midnight, which is too late for most people to sleep well.

Afternoon Booster Cutoffs

If you take an immediate-release booster in the afternoon, the cutoff time matters enormously:

Booster Type Latest Safe Time Why
Adderall IR (amphetamine) 2–3 PM 6-hour half-life, 4–6 hour duration
Ritalin IR (methylphenidate) 3–4 PM 3–4 hour half-life, shorter duration
Focalin IR (dexmethylphenidate) 3–4 PM Similar to Ritalin

The general rule: the last dose of the day should clear at least 6 hours before your target bedtime.

If you find yourself needing a booster after 3 PM regularly, the conversation with your prescriber is not "I need a later booster" — it's "my morning dose is wearing off too early." The solution may be a different formulation, a higher morning dose, or a different medication class, not a later booster.

The Stimulant Holiday Trap

Some patients skip their evening or weekend dose to "catch up on sleep." This is understandable but counterproductive. The rebound — a surge of ADHD symptoms as the medication clears — often produces more anxiety, restlessness, and rumination than the medication itself would have caused. The result is worse sleep, not better [20].

If you need a medication break for sleep, discuss it with your prescriber. A gradual taper or a switch to a shorter-acting formulation for those days may be more effective than abrupt cessation.

Melatonin: Timing, Dosing, and What the Research Says

Melatonin is the most commonly used supplement for ADHD-related sleep problems, and the evidence is genuinely supportive — but only when used correctly.

Timing Is Everything

The research is clear: melatonin's effect on sleep onset depends almost entirely on timing, not dose. A 2024 meta-analysis found that melatonin administered 1–2 hours before the desired bedtime (not at bedtime) produced the greatest reduction in sleep onset latency [21].

For ADHD brains, the optimal timing is 1–2 hours before dim light melatonin onset (DLMO) — the point when your body naturally starts producing melatonin. Since DLMO is delayed by 1.5–3 hours in ADHD, this means taking melatonin between 6:00–8:00 PM for a 10:30–11:00 PM target bedtime, not at the moment you want to fall asleep [22].

Dosing: Less Is More

Contrary to what the supplement shelves suggest, higher melatonin doses are not more effective for sleep onset. The evidence supports:

Age Group Recommended Dose Notes
Adults 0.5–3 mg 0.5 mg may be as effective as 3 mg with fewer side effects
Children (with prescriber guidance) 0.5–1 mg Start at the lowest possible dose
Extended-release Not recommended for sleep onset Use only for sleep maintenance

A 0.5 mg dose of melatonin taken 1–2 hours before target bedtime advanced dim light melatonin onset by approximately 90 minutes in adults with ADHD, according to a landmark study from the Netherlands [23]. Higher doses (5–10 mg) are no more effective for sleep onset and may cause morning grogginess, vivid dreams, and headaches.

What Melatonin Does and Doesn't Do

Melatonin is not a sedative. It is a chronobiotic — a signal that tells your body when to start the sleep process. It does not make you feel drowsy the way a sleep aid does. If you take melatonin at 10 PM and expect to feel sleepy by 10:15, you will be disappointed. If you take it at 7 PM and follow your sleep hygiene routine, you should notice an easier transition to sleep by 10:30.

Important Caveats

When Sleep Problems Signal the Wrong Dose or Formulation

Not all sleep problems during titration are timing issues. Some indicate that the medication itself — or the dose — is not right for you.

Signs That Timing Is the Problem

These are timing problems, and they respond to the adjustments described above.

Signs That the Medication or Dose Is the Problem

Signal What It May Mean
Sleep is poor even on days you skip medication The sleep problem is likely ADHD-related (DSPS, RLS, anxiety), not medication-induced
Nightmares or vivid dreams May indicate a medication that is too strong or a formulation that is releasing too aggressively
Restless, fragmented sleep (not just trouble falling asleep) Could be RLS that the medication is unmasking or worsening
Sleep improved initially on a lower dose, then worsened at a higher dose The dose is exceeding your therapeutic window — the benefits may not improve, but the sleep side effects will
You feel "wired" at bedtime even though your last dose was 10+ hours ago May indicate a metabolism issue (slow metabolizer) or a formulation that doesn't suit your physiology
Sleep is fine but you wake up feeling unrefreshed Could be sleep apnea — which is also elevated in ADHD populations — or medication-induced sleep architecture changes

The Test-Day Framework

If you're unsure whether your sleep problems are medication-related, try this: track your sleep for 3–5 consecutive days on your normal medication schedule, then for 3–5 days where you take your medication at the same dose but 1 hour earlier. Compare the sleep data. If sleep improves with earlier dosing, the problem is timing. If it doesn't, the problem is likely the medication itself or a co-occurring sleep disorder.

Tracking Sleep Alongside Medication

The most actionable insight from the research is this: you cannot optimize what you do not measure.

Sleep is the most commonly reported side effect affecting medication decisions, yet it's the one most likely to be remembered inaccurately. A patient who sleeps poorly 4 out of 7 nights may report "sleep is okay" at a medication review because the last two nights were fine. Structured tracking eliminates this error.

What to Track

Metric How to Track Why It Matters
Time you got into bed Note the time Distinguishes sleep onset insomnia from voluntary late bedtime
Estimated time you fell asleep Estimate within 15 minutes The key metric for sleep onset delay
Total sleep time From sleep to wake Volume matters for recovery
Wake-ups during the night Number + duration Sleep fragmentation is a different problem from onset insomnia
Restorative quality 1–5 scale How you feel matters more than the clock
Medication time + dose Note each dose The causal link between timing and sleep
Morning wake time Note the time Circadian regularity is a sleep hygiene factor

How Titrate Helps

The Titrate check-in system is designed to capture this data alongside your medication tracking. Each daily check-in includes a sleep log where you can record your bedtime, sleep onset, quality, and wake time — all linked to that day's medication dose and timing. Over 2–3 weeks, patterns emerge that are invisible to casual observation:

These patterns give you and your prescriber the data needed to make precision adjustments — not guesses.

Sleep Optimization Checklist

Use this checklist nightly during titration. Print it, save it as a note, or use the Titrate check-in system.

Morning (Set the Stage)

Afternoon (The Cutoff Window)

Evening (The Buffer Zone)

Bedtime (Execute)

Next Morning (Review)

When to Discuss Sleep with Your Prescriber

Bring sleep concerns to your prescriber's attention when:

  1. Sleep onset consistently takes longer than 60 minutes despite implementing the strategies above
  2. Total sleep time is regularly under 6 hours and you feel impaired during the day
  3. You wake up more than 2 times per night and can't get back to sleep within 30 minutes
  4. You experience nightmares, vivid dreams, or sleepwalking that you didn't have before medication
  5. You suspect a co-occurring sleep disorder — especially if you snore loudly, stop breathing during sleep, or experience leg sensations that make it hard to lie still
  6. Sleep problems are affecting your decision to continue medication — this is the most common reason for discontinuation, and it's a legitimate medical concern
  7. You're considering melatonin — check with your prescriber before starting, especially if you take other medications

What to Bring to the Appointment

Come with data, not impressions. Bring 2–3 weeks of sleep tracking records that show:

This converts a subjective complaint ("I have trouble sleeping") into an actionable data point ("On 8 of the last 14 days, sleep onset was over 60 minutes when my booster was taken after 2 PM, compared to 2 of 14 days when the booster was taken before 2 PM").

FAQ

Can I take my stimulant medication at night to help with sleep?

No. Stimulants are wakefulness-promoting agents. Taking them at night will delay sleep onset and worsen sleep quality. If you need medication coverage in the evening for ADHD symptoms, ask your prescriber about a non-stimulant option (guanfacine, clonidine) that can be dosed in the evening without disrupting sleep.

Does melatonin work for ADHD-related sleep problems?

Yes, when used correctly. The evidence is strongest for sleep onset delay, which is the most common ADHD sleep complaint. The key is timing: take melatonin 1–2 hours before your target bedtime, not at bedtime. Doses of 0.5–3 mg are sufficient; higher doses do not work better for sleep onset.

Should I skip my medication on weekends to catch up on sleep?

Skipping doses creates a rebound effect where ADHD symptoms surge as the medication clears, often producing worse sleep than the medication itself would. If you need a medication break, discuss it with your prescriber — a gradual taper or a temporary switch to a shorter-acting formulation may be more effective.

My sleep was fine before medication. Does this mean the medication isn't right for me?

Not necessarily. Sleep disruption is a direct pharmacological effect of stimulants, not a sign that the medication is wrong for you. Try adjusting the timing first — move your morning dose earlier and your last booster earlier. If sleep doesn't improve after these timing adjustments, then discuss the dose or formulation with your prescriber.

Can non-stimulants improve my sleep?

Some non-stimulants can improve sleep — particularly guanfacine and clonidine, which are sedating and often prescribed for evening use. Atomoxetine is less predictable: it improves sleep for some patients (by reducing daytime ADHD symptoms) and worsens it for others (by increasing noradrenergic tone).

How long does it take for sleep to normalize after starting a stimulant?

For some patients, sleep disruption is worst in the first 1–2 weeks and improves as the body adapts. For others, the sleep effects persist at the same intensity throughout treatment. If sleep hasn't improved after 2 weeks of consistent timing adjustments, it's unlikely to resolve on its own.

Is it safe to take sleep aids (diphenhydramine, doxylamine) with ADHD medication?

Over-the-counter sleep aids are not recommended for long-term use. They produce tolerance, next-day sedation, and can interact with stimulant medication in ways that are poorly studied. Melatonin is a safer option for sleep onset, and cognitive behavioral therapy for insomnia (CBT-I) is the gold standard non-pharmacological treatment for chronic insomnia — including in ADHD populations.

I wake up multiple times during the night. Is this the medication?

Possibly, but sleep maintenance insomnia is less directly linked to stimulant timing than sleep onset insomnia. If you're waking up in the middle of the night, consider: sleep apnea (more common in ADHD), RLS/PLMS, anxiety, or a medication that's wearing off too early and causing a rebound. Track your data and bring it to your prescriber.

Key Takeaways

  1. Sleep problems in ADHD are not a sign of weakness or poor discipline — they reflect real biological differences in circadian timing, dopamine regulation, and arousal control.

  2. Up to 75% of adults with ADHD have delayed sleep phase syndrome — a circadian rhythm disorder where melatonin release is delayed by 1.5–3 hours. This is the most common ADHD sleep problem, not "insomnia."

  3. Stimulant medications affect sleep architecture — they suppress REM sleep (20–30% reduction), delay sleep onset, and can reduce total sleep time. These are pharmacological effects, not side effects.

  4. Timing is the most powerful sleep intervention you can control — take your stimulant within 30 minutes of waking, and observe strict cutoff times for afternoon boosters (2–3 PM for amphetamine, 3–4 PM for methylphenidate).

  5. Melatonin works for ADHD-related sleep onset delay when timed correctly — take 0.5–3 mg, 1–2 hours before target bedtime, not at bedtime. More is not better.

  6. Non-stimulants offer a different sleep profile — guanfacine and clonidine are sedating and can be leveraged for sleep, while atomoxetine is neutral or mildly activating.

  7. Track everything — sleep data linked to medication timing reveals patterns that are invisible to memory. Without tracking, you and your prescriber are making decisions on incomplete information.

  8. Sleep problems that don't respond to timing adjustments may signal the wrong dose or formulation — bring your tracking data to your prescriber and discuss alternatives.

Track Your Sleep with Titrate

You're already tracking your medication dose, timing, and side effects. Add sleep to the picture, and you'll see patterns that make titration decisions clearer.

The Titrate check-in system includes a dedicated sleep log that captures bedtime, sleep onset, total sleep time, quality, and wake-ups — all linked to that day's medication data. Over 2–3 weeks, you'll see exactly how your medication timing affects your sleep, giving you and your prescriber the data to make precision adjustments.

[Start tracking your sleep alongside your medication →]

References

  1. Hvolby A. Associations of sleep disturbance with ADHD: implications for treatment. Atten Defic Hyperact Disord. 2015;7(1):1-18.

  2. Wynchank D, Bijlenga D, Beekman AT, Kooij JJ, Penninx BW. Adult attention-deficit/hyperactivity disorder (ADHD) and insomnia: an analysis of the NESDA study. Sleep Med. 2017;40:47-53.

  3. Van der Heijden KB, Smits MG, Van Someren EJ, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int. 2005;22(3):559-570.

  4. Kooij JJ, Bijlenga D. The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs. Expert Rev Neurother. 2013;13(10):1107-1116.

  5. Cortese S, Konofal E, Lecendreux M, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005;28(8):1007-1013.

  6. Oner P, Dirik EB, Taner Y, Caykoylu A, Anlar O. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med. 2007;213(3):269-276.

  7. Konofal E, Lecendreux M, Cortese S. Sleep and ADHD. Sleep Med. 2010;11(7):652-658.

  8. Owens JA. The ADHD and sleep conundrum: a review. J Dev Behav Pediatr. 2005;26(4):312-322.

  9. HealthRX. Adderall XR Sleep Architecture Impact: What the Clinical Evidence Shows. 2024. Review of polysomnographic data on amphetamine-induced REM suppression.

  10. Kooij JJ, Middelkoop HA, van Gils K, Buitelaar JK. The effect of stimulants on nocturnal motor activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry. 2001;62(12):952-956.

  11. Faraone SV. The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(11):1086-1090.

  12. Surman CBH, Roth T. ADHD and sleep: recent advances and future directions. Curr Psychiatry Rep. 2021;23(9):61.

  13. Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144-1153.

  14. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112-120.

  15. Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1067-1074.

  16. HMP Global Learning Network. ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice. Psychiatry & Behavioral Health Learning Network. 2024.

  17. Nasser A, Liranso T, Adewole T, et al. A phase 3, randomized, double-blind, placebo-controlled trial of viloxazine extended-release in adults with ADHD. J Clin Psychiatry. 2022;83(4):21m14137.

  18. Lack LC, Gradisar M, Van Someren EJ, Wright HR, Lushington K. The relationship between insomnia and body temperatures. Sleep Med Rev. 2008;12(4):307-317.

  19. Chen HY, Chen HL, Lin YJ, et al. The effect of weighted blankets on sleep quality and anxiety in adults with insomnia: a randomized controlled trial. J Sleep Res. 2022;31(4):e13574.

  20. Martikainen JA, Kautiainen H, Hinkka-Yli-Salomäki S, et al. The effect of drug holidays on sleep in children with ADHD: a prospective study. Eur Child Adolesc Psychiatry. 2020;29(4):535-545.

  21. Cruz-Sanabria F, Bruno S, Crippa A, et al. Optimizing the time and dose of melatonin as a sleep-promoting drug: a systematic review of randomized controlled trials and dose-response meta-analysis. J Pineal Res. 2024;76(5):e12985.

  22. Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007;46(2):233-241.

  23. Bijlenga D, Van Someren EJ, Gruber R, et al. The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD? Sleep Med Rev. 2019;47:80-91.

  24. Edemann-Callesen H, Andersen HK, Ussing A, et al. Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation. EClinicalMedicine. 2023;61:102048.